Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Abdalraheim Mustafa: Comparative Analysis of Thrombophilia and Thrombocytosis in Clinical Practice
Apr 17, 2026, 13:27

Abdalraheim Mustafa: Comparative Analysis of Thrombophilia and Thrombocytosis in Clinical Practice

Abdalraheim Mustafa, Family Medicine Physician at Dr. Sulaiman Al Habib Medical Group, Senior Specialist at World Organization of Family Doctors, shared a post on LinkedIn:

“This is a clear comparison between two diseases, Thrombophilia and Thrombocytosis, which are often confused with each other:

  • Thrombophilia

Definition: high tendency to form clots (hypercoagulable state)

Platelets: Normal

Causes:

  1. Inherited: Factor V Leiden, Protein C/S deficiency
  2. Acquired: APS, cancer, pregnancy, OCPs

Clinical: DVT, PE, recurrent miscarriage

Diagnosis

  1. Thrombophilia screen (genetic plus coagulation tests)
  2. Lupus anticoagulant, anticardiolipin antibodies

Management: Anticoagulation (DOAC / LMWH / warfarin)

  • Thrombocytosis

Definition: Platelets more than 450,000/µL

Causes:

  1. Reactive: infection, inflammation, iron deficiency
  2. Primary: essential thrombocythemia (MPN)

Clinical: Often asymptomatic, with/without thrombosis or bleeding

Diagnosis

  • CBC (high platelets)
  • Peripheral smear
  • JAK2 mutation testing (if primary suspected)

Management:

  • Reactive – treat cause
  • Primary – aspirin with/without hydroxyurea

Key Difference

  • Thrombophilia – clotting disorder (coagulation factors)
  • Thrombocytosis – high platelets

References (Latest Evidence-Based)

  1. NICE Guidelines (VTE management and thrombophilia testing) 2025.
  2. ASH Guidelines for VTE and Thrombophilia 2024–2025.
  3. UpToDate: Thrombophilia and Thrombocytosis (2026 updates).
  4. WHO Classification of Myeloid Neoplasms 2024.
  5. Harrison’s Principles of Internal Medicine, 21st Edition.”

Stay updated with Hemostasis Today.